Thursday, March 01, 2012 7:12:10 PM
Can you imagine the boardrooms of all the big pharma firms, with outside directors asking the boys who run the firm, "You could have bought this bioelectric or whatever the name is for a couple of billion, before they got the approvals and we would have had the patented jump on every pharma firm in the world, by controlling the device pain treatment market, where were you guys?
And then, "On a multiple basis BioWho is going to do a billion a year globally on just the PMS patch and you guys let this one get away? Why didn't the guys at the FDA let us know? What was going on? Was everyone asleep?" Presidents will be diving under the table.
Can you hear the whining and gnashing of teeth? My take is whoever gets BIEL is going to be in charge for a while and it may just be BIEL in its present form. If they get FDA approval, which is only logical, given that they already have it on the post-op eye surgery device, maybe they will have enough dough in the kitty to rock and roll.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM